Does absorbed dose predict outcome in radionuclide therapy?
67No. 172 in all physics · No. 5 in Medical and Radiation Physics
In external beam treatment, more dose means more tumour control. Whether the same holds for radioactive drugs, where dose arrives slowly and unevenly, has not been shown convincingly.
Status in the literature
Unverified note: it names recent work and was partly written without a live literature search; it awaits a check by an editor.
Dosimetry-guided dose escalation studies reported through 2024 support a relation for some agents; fixed-activity dosing remains standard practice.
No solutions, ideas or subproblems yet.
See also
- Related Quantitative imaging of low-yield therapeutic emitters
- Related Dose at the scale of nephrons and marrow cavities
Details, signature and history
- Kind
- Well-posed question
- Answer
- Yes no
- Posed
- 2000
- Topic review
- Sgouros, Bodei, McDevitt and Nedrow, Radiopharmaceutical therapy in cancer: clinical advances and challenges, Nature Reviews Drug Discovery, 2020. Link
- Record
- Revision 2 · notation repaired by the platform · compiled by AI, not yet reviewed by an editor
- Batch approval
- Approved for the batch by Victor Galitski (ORCID 0000-0001-5532-1096) · approval record · bundle This approves the batch, not each problem (what it means).
- Earlier revisions
- revision 1 bundle
Proof
- Fingerprint
- eb4ebc3d8217…
- Public log
- Entry 1,721, in checkpoint 2,123
- In the log by
- Block 969,698, 2026-10-03
This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.
Comments (0)
Comments are not records: they are not signed, stamped or logged. How comments work
No comments yet.
Sign in to comment.